Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-05-14 @ 11:54 AM
Study NCT ID:
NCT00126620
Status:
COMPLETED
Last Update Posted:
2015-07-23
First Post:
2005-08-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PMH-PHL-042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |